These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1980256)

  • 1. [Antihypertensive effect of naftopidil (KT-611), a novel alpha 1-adrenoceptor antagonist, in freely moving experimental hypertensive rats and dogs].
    Kawasaki H; Nakamura S; Takasaki K; Iwamoto T; Ohjimi H; Kushiku K; Furukawa T
    Nihon Yakurigaku Zasshi; 1990 Sep; 96(3):129-39. PubMed ID: 1980256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of prazosin and naftopidil on pelvic blood flow and nitric oxide synthase levels in spontaneously hypertensive rats.
    Yono M; Yamamoto Y; Imanishi A; Yoshida M; Ueda S; Latifpour J
    J Recept Signal Transduct Res; 2008; 28(4):403-12. PubMed ID: 18702011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
    Buisson-Defferier S; Hibert M; van den Buuse M
    Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Yu SM; Hsu SY; Ko FN; Chen CC; Huang YL; Huang TF; Teng CM
    Br J Pharmacol; 1992 Aug; 106(4):797-801. PubMed ID: 1356567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
    J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of a novel calcium antagonist, SD-3211, in experimental hypertensive rats.
    Takada T; Miyawaki N; Kageyama M; Matsuno K; Ishida N; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):855-62. PubMed ID: 1725898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of alpha 1-adrenoceptor-mediated vascular contraction by urapidil in isolated arterial strips of spontaneously hypertensive rats.
    Aoki K; Asano M; Matsuda T
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):167-78. PubMed ID: 2459548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hypertension effect of vanylidilol: a phenylaldehyde alpha/beta-adrenoceptor blocker with endothelium-dependent and K+ channels opening-associated vasorelaxant activities.
    Chiu CC; Wu JR; Lee CH; Liou SF; Dai ZK; Chen IJ; Yeh JL
    Pharmacology; 2004 Mar; 70(3):140-51. PubMed ID: 14752234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist on plasma lipid and vascular reactivity in hyperlipidaemic rats.
    Sheu JR; Peng IH; Lee YM; Yen MH
    Clin Exp Pharmacol Physiol; 1996 Mar; 23(3):207-13. PubMed ID: 8934609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of the novel potassium channel activator SKP-450 and its major metabolites in rats.
    Shin HS; Seo HW; Oh JH; Lee BH
    Arzneimittelforschung; 1998 Oct; 48(10):969-78. PubMed ID: 9825113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
    Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
    Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.